Literature DB >> 2988592

Production of plasminogen activators by human T-cell leukaemia virus-transformed human T cell lines.

S Hinuma, S Honda, K Tsukamoto, K Sugamura, Y Hinuma.   

Abstract

Six human T cell lines HAMA, KUN, KAN, TCL-Haz, TCL-Ter, and TCL-Mor, which were transformed by a retrovirus, human T-cell leukaemia virus (HTLV), constitutively produced plasminogen activators (PAs) in culture supernatants. The amount of PAs produced varied among the cell lines. The PAs were distinguished by immunochemical analysis between two types: urokinase (UK)-type and non-UK-type. KUN, TCL-Ter, and HAMA mainly produced UK-type PA, whereas the other cell lines produced both types. Thus, HTLV-transformed T cell lines differ in the quality and quantity of the PAs they produce. The PAs in the culture supernatants of each cell line were separated into several mol. w forms on sodium dodecyl sulfate polyacrylamide gel electrophoresis. The results indicate that the same cell line produces PAs of different mol. wt. PA production by these cell lines was affected by treatment with phorbol miristate acetate, concanavalin A, and phytohaemagglutinin; the effects were substantially different in each cell line. The data described here indicate that HTLV-transformed T cell lines constitutively produce PAs which are very heterogeneous in both quality and quantity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2988592      PMCID: PMC1977089          DOI: 10.1038/bjc.1985.118

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  32 in total

1.  Human B cell, T cell and null cell leukaemic cell lines derived from acute lymphoblastic leukaemias.

Authors:  I Miyoshi; S Hiraki; T Tsubota; I Kubonishi; Y Matsuda; T Nakayama; H Kishimoto; I Kimura; H Masuji
Journal:  Nature       Date:  1977-06-30       Impact factor: 49.962

2.  Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma.

Authors:  Y Matsuoka; G E Moore; Y Yagi; D Pressman
Journal:  Proc Soc Exp Biol Med       Date:  1967 Aug-Sep

Review 3.  Synergistic effect of tumor virus transformation and tumor promoter treatment on the production of plasminogen activator by chick embryo fibroblasts.

Authors:  R H Goldfarb; J P Quigley
Journal:  Cancer Res       Date:  1978-12       Impact factor: 12.701

4.  Studies on the infectivity and cytopathology of Epstein-Barr virus in human lymphoblastoid cells.

Authors:  F E Durr; J H Monroe; R Schmitter; K A Traul; Y Hirshaut
Journal:  Int J Cancer       Date:  1970-11-15       Impact factor: 7.396

5.  Terminal deoxynucleotidyl transferase activity in a cell line (molt-4) derived from the peripheral blood of a patient with acute lymphoblastic leukemia.

Authors:  B I Sahai Srivastava; J Minowada
Journal:  Biochem Biophys Res Commun       Date:  1973-04-02       Impact factor: 3.575

6.  Macrophage plasminogen activator: modulation of enzyme production by anti-inflammatory steroids, mitotic inhibitors, and cyclic nucleotides.

Authors:  J D Vassalli; J Hamilton; E Reich
Journal:  Cell       Date:  1976-06       Impact factor: 41.582

7.  Plasminogen activator in early embryogenesis: enzyme production by trophoblast and parietal endoderm.

Authors:  S Strickland; E Reich; M I Sherman
Journal:  Cell       Date:  1976-10       Impact factor: 41.582

8.  High terminal deoxynucleotidyl transferase activity in a new T-cell line (RPMI 8402) of acute lymphoblastic leukemia origin.

Authors:  B I Srivastava; J Minowada; G E Moore
Journal:  J Natl Cancer Inst       Date:  1975-07       Impact factor: 13.506

9.  Transformation of human leukocytes by cocultivation with an adult T cell leukemia virus producer cell line.

Authors:  N Yamamoto; M Okada; Y Koyanagi; M Kannagi; Y Hinuma
Journal:  Science       Date:  1982-08-20       Impact factor: 47.728

10.  Establishment of a human plasma cell line in vitro.

Authors:  K H Burk; B Drewinko; J M Turjillo; M J Ahearn
Journal:  Cancer Res       Date:  1978-08       Impact factor: 12.701

View more
  2 in total

1.  Plasminogen activators in human colorectal neoplasia.

Authors:  J S Gelister; M Mahmoud; M R Lewin; P J Gaffney; P B Boulos
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-20

2.  Plasminogen activators in experimental colorectal neoplasia: a role in the adenoma-carcinoma sequence?

Authors:  J S Gelister; M R Lewin; H E Driver; F Savage; M Mahmoud; P J Gaffney; P B Boulos
Journal:  Gut       Date:  1987-07       Impact factor: 23.059

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.